Focus Groups on Cognitive Function in Psychosis
PRECOGNITION
2 other identifiers
observational
32
0 countries
N/A
Brief Summary
Cognitive deficits are commonly observed in people with mental disorders. In psychosis, these impairments are frequently present early in the course of the disorder and have a substantial impact on functional outcomes. This project will gain insight into the cognitive deficits that people with lived experience of psychosis and their carers perceive to be the most troublesome. To achieve this, the investigators will conduct two sets of focus groups. During the first set of focus groups, the investigators will aim to identify the cognitive deficits that individuals with psychosis and their carers consider to be the most impairing. The findings of these focus groups will provide important information about what areas of cognition and functioning should be considered in future analyses of large fully anonymised datasets collected in the past from individuals with psychosis. The focus groups will not form part of those analyses, but will provide input from people with lived experience of psychosis on what problems with thinking skills are the most important for them and that should be considered by further research. The second set of focus groups will enable the investigators to determine the participants' perception of potential risks and benefits associated with the dissemination of findings on cognitive function in psychosis, to ensure this is done in a manner that is sensitive to the wishes and needs of people with lived experience of psychosis. Each participant will be asked to attend one focus group, which will last approximately one hour. Focus groups will take place at the South London and Maudsley (SLaM) Trust or at the Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, although provision will be made for participants to also participate online.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2024
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 18, 2024
CompletedFirst Posted
Study publicly available on registry
April 15, 2024
CompletedStudy Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
ExpectedApril 15, 2024
April 1, 2024
1 month
March 18, 2024
April 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Individual perception of impairments due to cognitive deficits associated with psychosis
For each set of focus groups, thematic analysis will be conducted to identify the main cognitive deficits that people with lived experience with psychosis consider to be the most impairing, including deficits in working memory, executive function and attention. No structured scales or questionnaires will be used.
Autumn 2024
Study Arms (2)
Individuals with lived experience of psychosis
Individuals with lived experience of psychosis
Carers of individuals with lived experience of psychosis
Carers of individuals with lived experience of psychosis
Interventions
During the focus group, the investigators will explore the cognitive deficits that people with lived experience with psychosis and their carers consider to be the most impairing.
Eligibility Criteria
Individuals with lived experience with psychosis, including individuals with personal experience of psychosis, carers and family members
You may qualify if:
- Lived experience with psychosis, including individuals with personal experience of psychosis, carers and family members
- Current or past cognitive deficits
- Age between 18 and 65 years
- Able to provide informed consent
You may not qualify if:
- No lived experience with psychosis
- Traumatic brain injury
- Neurological or metabolic disorders associated with cognitive deficits
- On occasions where it is not possible for the protocol to be followed, i.e. due to language barriers, participants will not be consented into the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 18, 2024
First Posted
April 15, 2024
Study Start
June 1, 2024
Primary Completion
July 1, 2024
Study Completion (Estimated)
September 1, 2026
Last Updated
April 15, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share